Path and Bayesian network analyses in the complex design of a well-being survey via New Zealand’s Integrated Data Infrastructure
EU relaxes rules for gene-edited crops
Nature Biotechnology, Published online: 28 July 2026; doi:10.1038/s41587-026-03264-4
The new laws break away from 20-year-old restrictive GMO directives to give an official nod to plants made with new genomic techniques.
Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial
Nature Medicine, Published online: 28 July 2026; doi:10.1038/s41591-026-04552-x
This cluster-randomized phase 3 trial examining the effectiveness of integrated care pathways comparing usual care with the addition of MRI imaging (Coverscan), or a digitally enabled rehabilitation platform app, or both (Coverscan + app), or neither, found specialist Long COVID care improved fatigue response in all arms.
Reducing the diagnostic odyssey in rare disease: why screening is not the only answer
Nature Medicine, Published online: 28 July 2026; doi:10.1038/s41591-026-04542-z
The timely detection of rare diseases is crucial, and using a range of approaches will be key to reducing the diagnostic odyssey.
Global economic burden of depression in 154 countries from 2025 to 2050
Nature Medicine, Published online: 28 July 2026; doi:10.1038/s41591-026-04548-7
A macroeconomic modeling analysis across 154 countries estimates that depression will impose a US$12 trillion global economic burden between 2025 and 2050, equivalent to around 0.5% of the annual global GDP.
Maternal 6-valent group B Streptococcus vaccine in non-pregnant and pregnant females: a randomized phase 1/2 trial
Nature Medicine, Published online: 28 July 2026; doi:10.1038/s41591-026-04558-5
A phase 1/2 study found maternal hexavalent 6 polysaccharide−protein conjugate group B Streptococcus vaccine (GBS6) to be safe and immunogenic and to have induced antibody responses to vaccine serotypes in infants whose parent was vaccinated while pregnant.
The genetic architecture of fibromyalgia across 2.5 million individuals
Nature Medicine, Published online: 28 July 2026; doi:10.1038/s41591-026-04492-6
A multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals identifies 26 risk loci for fibromyalgia, including HTT, and finds genetic correlations with chronic pain and psychiatric and somatic disorders.
Comprehensive Human Vagus Nerve Map Unveiled
Scientists at Northwell Health’s Feinstein Institutes for Medical Research said they have released the world’s first comprehensive human vagus nerve anatomical map. The achievement could change our understanding of the autonomic nervous system and accelerate the development of bioelectronic medicine and neuromodulation therapies, according to the researchers.
The first dataset release, collected over three years from 30 human donors encompassing 60 vagus nerves, is now available to the global scientific community via SPARC Science.
The vagus nerve is the longest cranial nerve and a critical “information superhighway,” consisting of two main bundles (one on the left side of the neck and the other on the right side of the neck) containing more than 200,000 individual nerve fibers stretching from the brainstem to all major organs.
![Stavros Zanos, MD, PhD [Feinstein Institutes]](https://www.genengnews.com/wp-content/uploads/2026/07/Zanos-Stavros-fs-214x300.jpg)
The nerve manages automatic functions such as heart rate, breathing and digestion, and serves as the body’s “on/off switch” for immune response and inflammation. To better understand the function of each vagal fiber, this new dataset resource offers a 3D view into the intricate anatomy of the human vagus nerve, utilizing techniques such as microCT imaging, immunohistochemistry, and ultrasound.
By mapping the organization of fascicles and fibers, investigators expect to gain critical insights into how the vagus nerve communicates with various organs and influences human health and disease.
“This dataset represents a major step forward in bioelectronic medicine, offering the most detailed anatomical reconstruction of the human vagus nerve to date,” said Stavros Zanos, MD, PhD, associate professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes and co-leader of the project. “For the first time, we can visualize the vagus nerve’s complex architecture that will allow us to design more precise, effective and safe neuromodulation therapies and devices.”
The accomplishment marks a milestone that began with a $6.7 million National Institutes of Health (NIH) grant awarded to the Feinstein Institutes in October 2022 for its Reconstructing Vagal Anatomy (REVA) project, part of the NIH Common Fund’s SPARC program. The successful delivery of the map was supported by Peter J. Pappas, Jr., whose donation provided philanthropic support towards the goals of this project.
![Kevin J. Tracey, MD [[Feinstein Institutes]](https://www.genengnews.com/wp-content/uploads/2026/07/web_Tracey_Kevin_FIMR-300x205.jpg)
“Decoding the vagus nerve’s intricate language is an important advance for science and medicine,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes, Karches Family Distinguished Chair in Medical Research and author of the book The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes. “This knowledge will further empower researchers to re-engineer human biology and unlock novel therapies for future patients.”
The Feinstein Institutes for Medical Research is a global scientific leader in bioelectronic medicine and vagus nerve stimulation, where medical researchers use modern technology to develop new device-based therapies to treat disease and injury, according to a Feinstein spokesperson, who points out that the field of bioelectronic medicine integrates insights from neuroscience, molecular medicine and biomedical engineering, and researchers at the Feinstein Institutes leverage the connection between the brain and the immune system to develop bioelectronic medicine interventions.
![The vagus nerve helps regulate blood pressure, heart rate, sleep, mood, breathing, bladder function, digestion, and the immune system. [Feinstein Institutes]](https://www.genengnews.com/wp-content/uploads/2026/07/NEWS_what-is-the-vagus-nerve-300x205.jpg)
The discovery that initiated the field of bioelectronic medicine—called the “inflammatory reflex”—was made more than 30 years ago by Tracey, continues the Feinstein official. This discovery emerged from studies on vagus nerve signaling and showed that the brain and body communicate to regulate inflammation and, if uncontrolled, inflammation could lead to disease, said Tracey.
It was the first FDA-approved vagus nerve stimulation device in July 2025 to treat rheumatoid arthritis. Northwell Health was the first in the nation to implant the newly approved treatment in patients in August 2025.
Today, engineers, computer scientists, immunologists, neuroscientists and clinicians develop cutting-edge medicine, including neuroimmune modulation, miniature implants for stimulating and recording the vagus nerve, noninvasive ultrasound neuromodulation to suppress inflammation, and novel brain-computer interfaces to overcome injuries of the nervous system, according to a Feinstein Institutes statement. These collaborative efforts are focused on converging to create personalized, precise treatments that hold promise in treating acute and chronic diseases, often with fewer side effects compared to current therapies.
Scientists believe these treatments have the potential to enhance or replace existing treatments across a range of conditions such as arthritis, heart disease, inflammatory bowel diseases, diabetes, cancer, and autoimmune disorders. By producing bioelectronic medicine knowledge, disease and injury could one day be treated by our own nerves without costly and potentially harmful pharmaceuticals, predict a number of researchers.
The post Comprehensive Human Vagus Nerve Map Unveiled appeared first on GEN – Genetic Engineering and Biotechnology News.
Anthony Fauci’s pandemic-era diary entries
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Good morning. We’ve got a pretty juicy story from STAT’s Jason Mast for you today. Pour your coffee and scroll down.

